 | • レポートコード：QYR9NV17692 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療の中国市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のインド市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、Daiichi Sankyo、Eisai、Johnson & Johnson、Novartis、Pfizer） ・胆道閉鎖症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary Atresia Treatment development in North America, Europe and Asia-Pacific.
The key players covered in this study
AstraZeneca
Daiichi Sankyo
Eisai
Johnson & Johnson
Novartis
Pfizer
…
Market segment by Type, the product can be split into
Drug Treatment
Surgery Treatment
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
The study objectives of this report are:
To analyze global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Biliary Atresia Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biliary Atresia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biliary Atresia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Treatment
1.4.3 Surgery Treatment
1.5 Market by Application
1.5.1 Global Biliary Atresia Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biliary Atresia Treatment Market Size
2.2 Biliary Atresia Treatment Growth Trends by Regions
2.2.1 Biliary Atresia Treatment Market Size by Regions (2019-2025)
2.2.2 Biliary Atresia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Biliary Atresia Treatment Market Size by by Players
3.1.1 Global Biliary Atresia Treatment Revenue by by Players (2014-2019)
3.1.2 Global Biliary Atresia Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Biliary Atresia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Biliary Atresia Treatment Key Players Head office and Area Served
3.3 Key Players Biliary Atresia Treatment Product/Solution/Service
3.4 Date of Enter into Biliary Atresia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biliary Atresia Treatment Market Size by Type (2014-2019)
4.2 Global Biliary Atresia Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Biliary Atresia Treatment Market Size (2014-2019)
5.2 Biliary Atresia Treatment Key Players in North America
5.3 North America Biliary Atresia Treatment Market Size by Type
5.4 North America Biliary Atresia Treatment Market Size by Application
6 Europe
6.1 Europe Biliary Atresia Treatment Market Size (2014-2019)
6.2 Biliary Atresia Treatment Key Players in Europe
6.3 Europe Biliary Atresia Treatment Market Size by Type
6.4 Europe Biliary Atresia Treatment Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Biliary Atresia Treatment Market Size (2014-2019)
7.2 Biliary Atresia Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Biliary Atresia Treatment Market Size by Type
7.4 Asia-Pacific Biliary Atresia Treatment Market Size by Application
8 International Players Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Company Details
8.1.2 Company Description and Business Overview
8.1.3 Biliary Atresia Treatment Introduction
8.1.4 AstraZeneca Revenue in Biliary Atresia Treatment Business (2014-2019))
8.1.5 AstraZeneca Recent Development
8.2 Daiichi Sankyo
8.2.1 Daiichi Sankyo Company Details
8.2.2 Company Description and Business Overview
8.2.3 Biliary Atresia Treatment Introduction
8.2.4 Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2014-2019)
8.2.5 Daiichi Sankyo Recent Development
8.3 Eisai
8.3.1 Eisai Company Details
8.3.2 Company Description and Business Overview
8.3.3 Biliary Atresia Treatment Introduction
8.3.4 Eisai Revenue in Biliary Atresia Treatment Business (2014-2019)
8.3.5 Eisai Recent Development
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Company Details
8.4.2 Company Description and Business Overview
8.4.3 Biliary Atresia Treatment Introduction
8.4.4 Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2014-2019)
8.4.5 Johnson & Johnson Recent Development
8.5 Novartis
8.5.1 Novartis Company Details
8.5.2 Company Description and Business Overview
8.5.3 Biliary Atresia Treatment Introduction
8.5.4 Novartis Revenue in Biliary Atresia Treatment Business (2014-2019)
8.5.5 Novartis Recent Development
8.6 Pfizer
8.6.1 Pfizer Company Details
8.6.2 Company Description and Business Overview
8.6.3 Biliary Atresia Treatment Introduction
8.6.4 Pfizer Revenue in Biliary Atresia Treatment Business (2014-2019)
8.6.5 Pfizer Recent Development
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
Table Biliary Atresia Treatment Key Market Segments
Table Key Players Biliary Atresia Treatment Covered
Table Global Biliary Atresia Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Treatment Figures
Table Key Players of Drug Treatment
Figuer Surgery Treatment Figures
Table Key Players of Surgery Treatment
Table Global Biliary Atresia Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Biliary Atresia Treatment Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Biliary Atresia Treatment Report Years Considered
Figure Global Biliary Atresia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Biliary Atresia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Biliary Atresia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Biliary Atresia Treatment Market Share by Regions 2014-2019
Figure Global Biliary Atresia Treatment Market Share by Regions 2014-2019
Figure Global Biliary Atresia Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Biliary Atresia Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Biliary Atresia Treatment Market Share by by Players (2014-2019)
Figure Global Biliary Atresia Treatment Market Share by by Players in 2018
Table Global Biliary Atresia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biliary Atresia Treatment Product/Solution/Service
Table Date of Enter into Biliary Atresia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biliary Atresia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Biliary Atresia Treatment Market Size Share by Type (2014-2019)
Figure Global Biliary Atresia Treatment Market Size Market Share by Type (2014-2019)
Table Global Biliary Atresia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Biliary Atresia Treatment Market Size Share by Application (2014-2019)
Figure Global Biliary Atresia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Biliary Atresia Treatment Revenue Market Share by Application in 2018
Figure North America Biliary Atresia Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Biliary Atresia Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Biliary Atresia Treatment Market Share (2018-2019)
Table North America Biliary Atresia Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Biliary Atresia Treatment Market Share by Type 2014-2019
Table North America Biliary Atresia Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Biliary Atresia Treatment Market Share by Application 2014-2019
Figure Europe Biliary Atresia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Biliary Atresia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Biliary Atresia Treatment Market Share (2018-2019)
Table Europe Biliary Atresia Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Biliary Atresia Treatment Market Share by Type 2014-2019
Table Europe Biliary Atresia Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Biliary Atresia Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Biliary Atresia Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Biliary Atresia Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Biliary Atresia Treatment Market Share (2018-2019)
Table Asia-Pacific Biliary Atresia Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Biliary Atresia Treatment Market Share by Type 2014-2019
Table Asia-Pacific Biliary Atresia Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Biliary Atresia Treatment Market Share by Application 2014-2019
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Eisai Company Details
Table Eisai Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure Eisai Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table Eisai Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Biliary Atresia Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Biliary Atresia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Global Biliary Atresia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Biliary Atresia Treatment Market Size Share by Regions (2019-2025)
Figure Global Biliary Atresia Treatment Market Size Share by Regions in 2025
Figure North America Biliary Atresia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Biliary Atresia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Biliary Atresia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Biliary Atresia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Biliary Atresia Treatment Market Size by Product (2019-2025)
Figure Global Biliary Atresia Treatment Market Size by Product in 2025
Table Global Biliary Atresia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Biliary Atresia Treatment Market Size by Application (2019-2025)
Figure Global Biliary Atresia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
胆道閉鎖症治療のグローバル市場：規模・現状・予測2019-2025 Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market siz…- 原発性胆汁性肝硬変薬のグローバル市場調査 2019年 The global Primary Biliary Cirrhosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Primary Biliary Cirrhosis Drug volume and value at global level, regional level and company level. From a gl…
- 原発性胆汁性肝硬変薬のグローバル市場調査 2019年 The global Primary Biliary Cirrhosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Primary Biliary Cirrhosis Drug volume and value at global level, regional level and company level. From a gl…
- 胆石砕石器のグローバル市場調査 2019年 The global Biliary Lithotripter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Biliary Lithotripter volume and value at global level, regional level and company level. From a global perspective, th…
- HIV関連リポジストロフィー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx mill…